Literature DB >> 36061582

Dementia Prevention and Aromatherapy in Japan.

Katsuya Urakami1.   

Abstract

Until recently, it was thought that dementia prevention was not possible. However, a recent paper reported that 40% of the risk factors for developing dementia are modifiable. Large-scale clinical studies on dementia prevention and various initiatives to reduce the risk of developing dementia have been made worldwide. In addition to the introduction of a global initiative in dementia prevention, I also introduce the results of our research on the development of the Tottori method dementia prevention program and aromatherapy to approach olfactory impairment in Alzheimer's disease. ©2022 Tottori University Medical Press.

Entities:  

Keywords:  Alzheimer’s disease; MCI; aromatherapy; non-pharmacological treatment; olfactory impairment

Year:  2022        PMID: 36061582      PMCID: PMC9419217          DOI: 10.33160/yam.2022.08.001

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.371


  36 in total

1.  Multicentre population-based dementia prevalence survey in Japan: a preliminary report.

Authors:  Chiaki Ikejima; Akito Hisanaga; Kenichi Meguro; Tatsuo Yamada; Shinji Ouma; Yu Kawamuro; Kazushi Hyouki; Kenji Nakashima; Kenji Wada; Shigeto Yamada; Itaru Watanabe; Tatsuyuki Kakuma; Yoshiko Aoyama; Katsuyoshi Mizukami; Takashi Asada
Journal:  Psychogeriatrics       Date:  2012-06       Impact factor: 2.440

2.  beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease.

Authors:  T Kovács; N J Cairns; P L Lantos
Journal:  Neuropathol Appl Neurobiol       Date:  1999-12       Impact factor: 8.090

3.  [Examination and preventive intervention of dementia from the point of view of life style].

Authors:  Katsuya Urakami
Journal:  Nihon Ronen Igakkai Zasshi       Date:  2011

Review 4.  Clinical practice. Mild cognitive impairment.

Authors:  Ronald C Petersen
Journal:  N Engl J Med       Date:  2011-06-09       Impact factor: 91.245

Review 5.  Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications.

Authors:  Geert Jan Biessels; Florin Despa
Journal:  Nat Rev Endocrinol       Date:  2018-10       Impact factor: 43.330

Review 6.  Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.

Authors:  Subbiah Pugazhenthi; Limei Qin; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-05-06       Impact factor: 5.187

7.  Alcohol consumption and dementia risk: a dose-response meta-analysis of prospective studies.

Authors:  Wei Xu; Huifu Wang; Yu Wan; Chenchen Tan; Jieqiong Li; Lan Tan; Jin-Tai Yu
Journal:  Eur J Epidemiol       Date:  2017-01-17       Impact factor: 8.082

8.  Informant-based hearing difficulties and the risk for mild cognitive impairment and dementia.

Authors:  Maria Vassilaki; Jeremiah A Aakre; David S Knopman; Walter K Kremers; Michelle M Mielke; Yonas E Geda; Mary M Machulda; Razan Al Fakir; Chaitanya Undavalli; Rosebud O Roberts; Ronald C Petersen
Journal:  Age Ageing       Date:  2019-11-01       Impact factor: 10.668

9.  Social isolation, cognitive reserve, and cognition in healthy older people.

Authors:  Isobel E M Evans; David J Llewellyn; Fiona E Matthews; Robert T Woods; Carol Brayne; Linda Clare
Journal:  PLoS One       Date:  2018-08-17       Impact factor: 3.240

10.  Aromatherapy improves cognitive dysfunction in senescence-accelerated mouse prone 8 by reducing the level of amyloid beta and tau phosphorylation.

Authors:  Michiaki Okuda; Yuki Fujita; Yuki Takada-Takatori; Hachiro Sugimoto; Katsuya Urakami
Journal:  PLoS One       Date:  2020-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.